Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CTMX |
---|---|---|
09:32 ET | 6661 | 1.225 |
09:34 ET | 4134 | 1.235 |
09:36 ET | 100 | 1.235 |
09:38 ET | 2903 | 1.245 |
09:41 ET | 3200 | 1.24 |
09:43 ET | 1600 | 1.2399 |
09:45 ET | 716 | 1.23 |
09:50 ET | 1840 | 1.23 |
09:52 ET | 713 | 1.235 |
09:54 ET | 558 | 1.23 |
09:56 ET | 1015 | 1.23 |
09:57 ET | 9415 | 1.235 |
09:59 ET | 300 | 1.235 |
10:01 ET | 300 | 1.235 |
10:03 ET | 1200 | 1.235 |
10:06 ET | 300 | 1.235 |
10:08 ET | 29470 | 1.225 |
10:10 ET | 900 | 1.225 |
10:12 ET | 1214 | 1.235 |
10:14 ET | 200 | 1.235 |
10:15 ET | 1400 | 1.235 |
10:17 ET | 4719 | 1.235 |
10:19 ET | 200 | 1.235 |
10:21 ET | 847 | 1.2303 |
10:24 ET | 848 | 1.235 |
10:26 ET | 848 | 1.24 |
10:30 ET | 2100 | 1.235 |
10:32 ET | 1526 | 1.23 |
10:33 ET | 200 | 1.23 |
10:35 ET | 1252 | 1.24 |
10:37 ET | 800 | 1.23 |
10:39 ET | 200 | 1.23 |
10:42 ET | 100 | 1.23 |
10:44 ET | 900 | 1.24 |
10:46 ET | 548 | 1.23 |
10:48 ET | 400 | 1.24 |
10:50 ET | 4567 | 1.235 |
10:51 ET | 321 | 1.23 |
10:53 ET | 999 | 1.23 |
10:55 ET | 7875 | 1.225 |
10:57 ET | 1731 | 1.22 |
11:00 ET | 1000 | 1.215 |
11:02 ET | 800 | 1.215 |
11:04 ET | 700 | 1.215 |
11:06 ET | 1300 | 1.215 |
11:08 ET | 1148 | 1.215 |
11:09 ET | 825 | 1.215 |
11:11 ET | 500 | 1.215 |
11:13 ET | 2723 | 1.225 |
11:15 ET | 300 | 1.225 |
11:20 ET | 200 | 1.225 |
11:22 ET | 796 | 1.22 |
11:27 ET | 4700 | 1.225 |
11:29 ET | 800 | 1.225 |
11:31 ET | 1700 | 1.225 |
11:33 ET | 1100 | 1.23 |
11:36 ET | 2300 | 1.23 |
11:38 ET | 6800 | 1.235 |
11:40 ET | 1596 | 1.235 |
11:42 ET | 200 | 1.235 |
11:44 ET | 100 | 1.23 |
11:47 ET | 700 | 1.23 |
11:49 ET | 2800 | 1.235 |
11:54 ET | 3600 | 1.22 |
11:56 ET | 800 | 1.22 |
11:58 ET | 200 | 1.22 |
12:00 ET | 200 | 1.22 |
12:02 ET | 900 | 1.22 |
12:03 ET | 1435 | 1.22 |
12:05 ET | 400 | 1.22 |
12:07 ET | 100 | 1.22 |
12:09 ET | 1100 | 1.22 |
12:12 ET | 100 | 1.22 |
12:14 ET | 200 | 1.22 |
12:16 ET | 1000 | 1.2289 |
12:18 ET | 400 | 1.22 |
12:20 ET | 1100 | 1.22 |
12:21 ET | 800 | 1.225 |
12:23 ET | 200 | 1.22 |
12:25 ET | 200 | 1.22 |
12:27 ET | 100 | 1.22 |
12:30 ET | 1300 | 1.22 |
12:32 ET | 100 | 1.22 |
12:34 ET | 100 | 1.22 |
12:36 ET | 100 | 1.22 |
12:38 ET | 2200 | 1.22 |
12:41 ET | 3872 | 1.225 |
12:43 ET | 1300 | 1.225 |
12:45 ET | 548 | 1.23 |
12:48 ET | 100 | 1.225 |
12:50 ET | 400 | 1.225 |
12:52 ET | 500 | 1.225 |
12:54 ET | 2592 | 1.2204 |
12:56 ET | 1300 | 1.225 |
12:57 ET | 200 | 1.22 |
12:59 ET | 4688 | 1.225 |
01:01 ET | 2324 | 1.225 |
01:03 ET | 800 | 1.225 |
01:06 ET | 100 | 1.22 |
01:08 ET | 2878 | 1.2204 |
01:10 ET | 900 | 1.22 |
01:12 ET | 840 | 1.225 |
01:14 ET | 300 | 1.225 |
01:15 ET | 400 | 1.225 |
01:17 ET | 700 | 1.225 |
01:19 ET | 100 | 1.225 |
01:21 ET | 1400 | 1.225 |
01:24 ET | 400 | 1.225 |
01:26 ET | 300 | 1.225 |
01:28 ET | 3904 | 1.225 |
01:30 ET | 2373 | 1.225 |
01:32 ET | 400 | 1.225 |
01:33 ET | 11370 | 1.235 |
01:35 ET | 100 | 1.235 |
01:37 ET | 600 | 1.24 |
01:39 ET | 600 | 1.235 |
01:42 ET | 300 | 1.235 |
01:44 ET | 2689 | 1.235 |
01:46 ET | 889 | 1.235 |
01:48 ET | 700 | 1.235 |
01:50 ET | 2722 | 1.235 |
01:51 ET | 300 | 1.235 |
01:53 ET | 2895 | 1.24 |
01:55 ET | 1493 | 1.24 |
01:57 ET | 3000 | 1.25 |
02:00 ET | 100 | 1.245 |
02:02 ET | 400 | 1.245 |
02:04 ET | 4175 | 1.245 |
02:06 ET | 300 | 1.25 |
02:08 ET | 700 | 1.245 |
02:09 ET | 2100 | 1.245 |
02:11 ET | 400 | 1.25 |
02:13 ET | 600 | 1.25 |
02:15 ET | 800 | 1.25 |
02:18 ET | 900 | 1.245 |
02:20 ET | 2472 | 1.245 |
02:22 ET | 3200 | 1.245 |
02:24 ET | 3619 | 1.245 |
02:26 ET | 800 | 1.245 |
02:27 ET | 500 | 1.245 |
02:29 ET | 600 | 1.25 |
02:31 ET | 4300 | 1.245 |
02:33 ET | 600 | 1.245 |
02:36 ET | 658 | 1.25 |
02:38 ET | 300 | 1.245 |
02:40 ET | 100 | 1.24 |
02:42 ET | 1400 | 1.245 |
02:45 ET | 2895 | 1.245 |
02:49 ET | 671 | 1.245 |
02:51 ET | 100 | 1.245 |
02:54 ET | 200 | 1.245 |
02:56 ET | 451 | 1.25 |
02:58 ET | 600 | 1.245 |
03:00 ET | 200 | 1.245 |
03:05 ET | 3382 | 1.245 |
03:07 ET | 700 | 1.245 |
03:09 ET | 360 | 1.245 |
03:12 ET | 500 | 1.25 |
03:14 ET | 1987 | 1.245 |
03:18 ET | 100 | 1.245 |
03:20 ET | 500 | 1.245 |
03:21 ET | 1287 | 1.25 |
03:23 ET | 4200 | 1.245 |
03:25 ET | 400 | 1.245 |
03:27 ET | 300 | 1.245 |
03:30 ET | 1100 | 1.245 |
03:32 ET | 5656 | 1.245 |
03:34 ET | 900 | 1.245 |
03:36 ET | 2500 | 1.245 |
03:38 ET | 9606 | 1.255 |
03:39 ET | 100 | 1.26 |
03:41 ET | 1100 | 1.25 |
03:45 ET | 700 | 1.25 |
03:48 ET | 5549 | 1.26 |
03:50 ET | 205 | 1.26 |
03:52 ET | 300 | 1.255 |
03:54 ET | 300 | 1.255 |
03:56 ET | 3715 | 1.255 |
03:57 ET | 4988 | 1.26 |
03:59 ET | 37008 | 1.27 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
CytomX Therapeutics Inc | 96.9M | 9.3x | --- |
Spero Therapeutics Inc | 67.6M | 4.3x | --- |
Aytu Biopharma Inc | 16.4M | -1.0x | --- |
2Seventy Bio Inc | 241.6M | -1.5x | --- |
Fortress Biotech Inc | 44.5M | -0.5x | --- |
Acorda Therapeutics Inc | 17.4K | 0.0x | --- |
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company focused on developing novel conditionally activated biologics designed to be localized to the tumor microenvironment. It is advancing potential first-in-class and best-in-class antibody-based therapeutics created using its PROBODY therapeutic technology platform. Its pipeline comprises therapeutic candidates across multiple treatment modalities including antibody-drug conjugates (ADCs), T-cell engagers, and immune modulators such as cytokines. Its clinical-stage pipeline includes CX-904, CX-2051 and CX-801. CX-904 is a conditionally activated T-cell-engaging antibody targeting the epidermal growth factor receptor on tumor cells and the CD3 receptor on T cells and partnered with Amgen in a global co-development alliance. CX-2051 is a conditionally activated ADC directed toward epithelial cell adhesion molecule (EpCAM) with potential applicability across multiple EpCAM-expressing epithelial cancers.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $96.9M |
---|---|
Revenue (TTM) | $119.6M |
Shares Outstanding | 78.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.04 |
EPS | $0.14 |
Book Value | $-0.70 |
P/E Ratio | 9.3x |
Price/Sales (TTM) | 0.8 |
Price/Cash Flow (TTM) | 7.5x |
Operating Margin | 4.79% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.